The Last Refuge Article RatingPresident Trump Announces Executive Order to Lower Prescription Drug Prices through MFN Policy - The Last Refuge
- Bias Rating
6% Center
- Reliability
40% ReliableAverage
- Policy Leaning
12% Somewhat Conservative
- Politician Portrayal
-18% Negative
Continue For Free
Create your free account to see the in-depth bias analytics and more.
Continue
Continue
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates. Already a member: Log inBias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Sentiments
N/A
- Liberal
- Conservative
| Sentence | Sentiment | Bias |
|---|---|---|
Unlock this feature by upgrading to the Pro plan. | ||
Reliability Score Analysis
Policy Leaning Analysis
Politician Portrayal Analysis
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Contributing sentiments towards policy:
55% : President Trump has announced via Truth Social that he will sign an executive order to structurally create a "most favored nation" (MFN) policy toward USA drug manufacturing prices.50% : In addition to the uncertainty created by the threat of tariffs, there is little incentive to invest in the EU and significant drivers to relocate to the US.
49% : In a proactive move, the European Federation of Pharmaceutical Industries and Associations (EFPIA), went to the European Commission (EC) in April to hold talks with Commission President Ursula von der Leyen, calling for radical change and holding the threat of an exodus to the U.S. over the EC president's head. PRESS RELEASE - Today, CEOs of the research-based pharmaceutical industry issued a stark warning to President von der Leyen that unless Europe delivers rapid, radical policy change then pharmaceutical research, development and manufacturing is increasingly likely to be directed towards the US.
47% : President Trump - "For many years the World has wondered why Prescription Drugs and Pharmaceuticals in the United States of America were SO MUCH HIGHER IN PRICE THAN THEY WERE IN ANY OTHER NATION, SOMETIMES BEING FIVE TO TEN TIMES MORE EXPENSIVE THAN THE SAME DRUG, MANUFACTURED IN THE EXACT SAME LABORATORY OR PLANT, BY THE SAME COMPANY???
41% : [source] President Trump is on the cusp of announcing a big change in tariffs against foreign pharmaceutical companies in an effort to get the manufacturing of medicines brought back to the USA.
*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.
